Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03770988
Recruitment Status : Not yet recruiting
First Posted : December 10, 2018
Last Update Posted : February 22, 2019
Sponsor:
Information provided by (Responsible Party):
Yonsei University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : August 31, 2020
  Estimated Study Completion Date : August 31, 2020